Skip to main content
. 2017 Jul 9;2017:9764843. doi: 10.1155/2017/9764843

Table 2.

XOD activity of CF, CB, and CC12 mixture and their marker compounds.

Sample treatment Concentration (μg/ml) % inhibition IC50 (μg/ml)
CF 100 5.3 ± 2.8 >500
250 8.9 ± 4.1
500 39.2 ± 6.9
CB 100 31.2 ± 2.6 143
250 100.3 ± 3.1
500 98.4 ± 0.1
CC12 mixture 100 23.2 ± 0.4 153.8
250 94.3 ± 3.2
500 101.0 ± 0.2
Chlorogenic acid 62.5 24.0 ± 1.7 103.8
125 63.6 ± 1.5
250 107.3 ± 0.6
3,4-Dicaffeoylquinic acid 62.5 21.0 ± 1.5 79.7
125 104.6 ± 2.6
250 85.0 ± 1.2
Coumarin 62.5 22.8 ± 0.1 95.2
125 75.1 ± 1.0
250 103.9 ± 0.7
Cinnamaldehyde 62.5 101.2 ± 3.2 43.7
125 126.3 ± 5.6
250 118.8 ± 35.1
trans-Cinnamic acid 62.5 54.3 ± 0.7 58.8
125 96.7 ± 1.9
250 114.9 ± 0.4
o-Methoxycinnamaldehyde 62.5 104.7 ± 0.2 25.7
125 101.2 ± 0.2
250 100.0 ± 0.4
Allopurinol 6.25 51.7 ± 0.7
12.5 71.7 ± 0.1
25 80.3 ± 0.3

Chrysanthemum indicum Linne flower ethanol extract; CB, Cinnamomum cassia (L.) J. Persl bark ethanol extract; CC, mixture of CF and CB. Data are expressed as the mean ± SEM.